These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 26759237)

  • 21. Epigenetic regulation of RhoB loss of expression in lung cancer.
    Mazières J; Tovar D; He B; Nieto-Acosta J; Marty-Detraves C; Clanet C; Pradines A; Jablons D; Favre G
    BMC Cancer; 2007 Nov; 7():220. PubMed ID: 18047684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of RASSF1A aberrant promoter hypermethylation in sputum from chronic smokers and ductal carcinoma in situ from breast cancer patients.
    Honorio S; Agathanggelou A; Schuermann M; Pankow W; Viacava P; Maher ER; Latif F
    Oncogene; 2003 Jan; 22(1):147-50. PubMed ID: 12527916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long non-coding RNA SNHG1 regulates zinc finger E-box binding homeobox 1 expression by interacting with TAp63 and promotes cell metastasis and invasion in Lung squamous cell carcinoma.
    Zhang HY; Yang W; Zheng FS; Wang YB; Lu JB
    Biomed Pharmacother; 2017 Jun; 90():650-658. PubMed ID: 28415044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypermethylation of RASSF1A and BLU tumor suppressor genes in non-small cell lung cancer: implications for tobacco smoking during adolescence.
    Marsit CJ; Kim DH; Liu M; Hinds PW; Wiencke JK; Nelson HH; Kelsey KT
    Int J Cancer; 2005 Mar; 114(2):219-23. PubMed ID: 15540210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TNFAIP8 regulates Hippo pathway through interacting with LATS1 to promote cell proliferation and invasion in lung cancer.
    Han Y; Tang Z; Zhao Y; Li Q; Wang E
    Mol Carcinog; 2018 Feb; 57(2):159-166. PubMed ID: 28926138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequent inactivation of RASSF1A, BLU, and SEMA3B on 3p21.3 by promoter hypermethylation and allele loss in non-small cell lung cancer.
    Ito M; Ito G; Kondo M; Uchiyama M; Fukui T; Mori S; Yoshioka H; Ueda Y; Shimokata K; Sekido Y
    Cancer Lett; 2005 Jul; 225(1):131-9. PubMed ID: 15922865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypermethylation of RASSF1A promoter is associated with the age at starting smoking and a poor prognosis in primary non-small cell lung cancer.
    Kim DH; Kim JS; Ji YI; Shim YM; Kim H; Han J; Park J
    Cancer Res; 2003 Jul; 63(13):3743-6. PubMed ID: 12839968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histone methylation-mediated silencing of miR-139 enhances invasion of non-small-cell lung cancer.
    Watanabe K; Amano Y; Ishikawa R; Sunohara M; Kage H; Ichinose J; Sano A; Nakajima J; Fukayama M; Yatomi Y; Nagase T; Ohishi N; Takai D
    Cancer Med; 2015 Oct; 4(10):1573-82. PubMed ID: 26256448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Silencing of tumor suppressor genes RASSF1A, SLIT2, and WIF1 by promoter hypermethylation in hereditary breast cancer.
    Alvarez C; Tapia T; Cornejo V; Fernandez W; Muñoz A; Camus M; Alvarez M; Devoto L; Carvallo P
    Mol Carcinog; 2013 Jun; 52(6):475-87. PubMed ID: 22315090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor-suppressive p53 Signaling Empowers Metastatic Inhibitor KLF17-dependent Transcription to Overcome Tumorigenesis in Non-small Cell Lung Cancer.
    Ali A; Bhatti MZ; Shah AS; Duong HQ; Alkreathy HM; Mohammad SF; Khan RA; Ahmad A
    J Biol Chem; 2015 Aug; 290(35):21336-51. PubMed ID: 25911104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DLC-1 suppresses non-small cell lung cancer growth and invasion by RhoGAP-dependent and independent mechanisms.
    Healy KD; Hodgson L; Kim TY; Shutes A; Maddileti S; Juliano RL; Hahn KM; Harden TK; Bang YJ; Der CJ
    Mol Carcinog; 2008 May; 47(5):326-37. PubMed ID: 17932950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The antineoplastic drug metformin downregulates YAP by interfering with IRF-1 binding to the YAP promoter in NSCLC.
    Jin D; Guo J; Wang D; Wu Y; Wang X; Gao Y; Shao C; Xu X; Tan S
    EBioMedicine; 2018 Nov; 37():188-204. PubMed ID: 30389502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prognostic value of RASSF1A promoter hypermethylation in non-small cell lung carcinoma: a systematic review and meta-analysis.
    Wang J; Wang B; Chen X; Bi J
    Carcinogenesis; 2011 Mar; 32(3):411-6. PubMed ID: 21156971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methylation of RASSF1A and CDH13 genes in individualized chemotherapy for patients with non-small cell lung cancer.
    Zhai X; Li SJ
    Asian Pac J Cancer Prev; 2014; 15(12):4925-8. PubMed ID: 24998565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specific reversal of tumor-suppressor gene promoter hypermethylation with bovine oocyte extract.
    Wang Z; Gao H; Wang H; Ren X; Bao L; Sa R; Wang J; Bai H; Yu H
    Oncol Rep; 2013 Jul; 30(1):179-84. PubMed ID: 23670097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Analysis of RASSF1A promoter hypermethylation in serum DNA of non-small cell lung cancer].
    Yu ZH; Wang YC; Chen LB; Song Y; Liu C; Xia XY; Lin Q; Ma CY
    Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):284-7. PubMed ID: 18788633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histone deacetylase 1 represses the small GTPase RhoB expression in human nonsmall lung carcinoma cell line.
    Wang S; Yan-Neale Y; Fischer D; Zeremski M; Cai R; Zhu J; Asselbergs F; Hampton G; Cohen D
    Oncogene; 2003 Sep; 22(40):6204-13. PubMed ID: 13679859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of DAPK and RASSF1A promoter hypermethylation in non-small cell lung cancer (NSCLC).
    Niklinska W; Naumnik W; Sulewska A; Kozłowski M; Pankiewicz W; Milewski R
    Folia Histochem Cytobiol; 2009; 47(2):275-80. PubMed ID: 19926549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers.
    Yanagawa N; Tamura G; Oizumi H; Kanauchi N; Endoh M; Sadahiro M; Motoyama T
    Lung Cancer; 2007 Oct; 58(1):131-8. PubMed ID: 17606310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased expression of RASSF1A tumor suppressor gene is associated with worse prognosis in clear cell renal cell carcinoma.
    Klacz J; Wierzbicki PM; Wronska A; Rybarczyk A; Stanislawowski M; Slebioda T; Olejniczak A; Matuszewski M; Kmiec Z
    Int J Oncol; 2016 Jan; 48(1):55-66. PubMed ID: 26648328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.